Northeast Financial Consultants’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.86M | Sell |
38,382
-449
| -1% | -$69K | 0.24% | 61 |
|
|
2025
Q1 | $6.44M | Buy |
38,831
+3
| +0% | +$469 | 0.29% | 54 |
|
|
2024
Q4 | $5.62M | Buy |
38,828
+191
| +0.5% | +$29.6K | 0.24% | 57 |
|
|
2024
Q3 | $6.26M | Buy |
38,637
+28
| +0.1% | +$4.46K | 0.27% | 55 |
|
|
2024
Q2 | $5.64M | Sell |
38,609
-959
| -2% | -$143K | 0.26% | 57 |
|
|
2024
Q1 | $6.26M | Buy |
39,568
+829
| +2% | +$132K | 0.31% | 55 |
|
|
2023
Q4 | $6.07M | Buy |
38,739
+3
| +0% | +$460 | 0.34% | 52 |
|
|
2023
Q3 | $6.03M | Sell |
38,736
-94
| -0.2% | -$15.5K | 0.38% | 50 |
|
|
2023
Q2 | $6.43M | Buy |
38,830
+1,460
| +4% | +$236K | 0.39% | 45 |
|
|
2023
Q1 | $5.79M | Sell |
37,370
-2,029
| -5% | -$328K | 0.37% | 50 |
|
|
2022
Q4 | $6.96M | Sell |
39,399
-2,414
| -6% | -$417K | 0.47% | 40 |
|
|
2022
Q3 | $6.83M | Sell |
41,813
-467
| -1% | -$79K | 0.5% | 38 |
|
|
2022
Q2 | $7.5M | Sell |
42,280
-1,546
| -4% | -$275K | 0.52% | 36 |
|
|
2022
Q1 | $7.77M | Buy |
43,826
+1,570
| +4% | +$267K | 0.45% | 47 |
|
|
2021
Q4 | $7.23M | Buy |
42,256
+1,566
| +4% | +$256K | 0.44% | 43 |
|
|
2021
Q3 | $6.57M | Sell |
40,690
-2,668
| -6% | -$455K | 0.44% | 42 |
|
|
2021
Q2 | $7.14M | Buy |
43,358
+66
| +0.2% | +$10.9K | 0.48% | 41 |
|
|
2021
Q1 | $7.12M | Buy |
43,292
+317
| +0.7% | +$51.3K | 0.54% | 36 |
|
|
2020
Q4 | $6.76M | Buy |
42,975
+2,407
| +6% | +$355K | 0.56% | 33 |
|
|
2020
Q3 | $6.04M | Buy |
40,568
+3,329
| +9% | +$493K | 0.55% | 33 |
|
|
2020
Q2 | $5.24M | Buy |
37,239
+8
| +0% | +$1.17K | 0.5% | 37 |
|
|
2020
Q1 | $4.88M | Buy |
37,231
+557
| +2% | +$79K | 0.55% | 34 |
|
|
2019
Q4 | $5.35M | Sell |
36,674
-2,117
| -5% | -$287K | 0.48% | 42 |
|
|
2019
Q3 | $5.02M | Sell |
38,791
-761
| -2% | -$100K | 0.51% | 44 |
|
|
2019
Q2 | $5.51M | Buy |
39,552
+122
| +0.3% | +$16.9K | 0.57% | 38 |
|
|
2019
Q1 | $5.51M | Buy |
39,430
+568
| +1% | +$76.1K | 0.61% | 36 |
|
|
2018
Q4 | $5.01M | Buy |
38,862
+6,073
| +19% | +$847K | 0.7% | 32 |
|
|
2018
Q3 | $4.53M | Buy |
32,789
+6,801
| +26% | +$904K | 1.24% | 18 |
|
|
2018
Q2 | $3.15M | Hold |
25,988
| – | – | 0.97% | 22 |
|
|
2018
Q1 | $3.33M | Sell |
25,988
-115
| -0.4% | -$15.5K | 1.12% | 22 |
|
|
2017
Q4 | $3.65M | Buy |
26,103
+115
| +0.4% | +$16K | 1.21% | 20 |
|
|
2017
Q3 | $3.38M | Buy |
25,988
+3,388
| +15% | +$449K | 1.24% | 18 |
|
|
2017
Q2 | $2.99M | Sell |
22,600
-156
| -0.7% | -$19.9K | 1.18% | 20 |
|
|
2017
Q1 | $2.83M | Hold |
22,756
| – | – | 1.18% | 16 |
|
|
2016
Q4 | $2.62M | Buy |
22,756
+1,060
| +5% | +$122K | 1.17% | 17 |
|
|
2016
Q3 | $2.56M | Buy |
21,696
+6,704
| +45% | +$813K | 1.08% | 21 |
|
|
2016
Q2 | $1.82M | Buy |
14,992
+40
| +0.3% | +$4.54K | 0.81% | 23 |
|
|
2016
Q1 | $1.62M | Sell |
14,952
-6,704
| -31% | -$694K | 0.85% | 23 |
|
|
2015
Q4 | $2.22M | Hold |
21,656
| – | – | 1.15% | 20 |
|
|
2015
Q3 | $2.02M | Hold |
21,656
| – | – | 1.03% | 21 |
|
|
2015
Q2 | $2.11M | Hold |
21,656
| – | – | 0.95% | 26 |
|
|
2015
Q1 | $2.18M | Sell |
21,656
-503
| -2% | -$51.2K | 0.99% | 24 |
|
|
2014
Q4 | $2.32M | Hold |
22,159
| – | – | 1.22% | 18 |
|
|
2014
Q3 | $2.36M | Hold |
22,159
| – | – | 1.3% | 19 |
|
|
2014
Q2 | $2.32M | Hold |
22,159
| – | – | 1.31% | 16 |
|
|
2014
Q1 | $2.18M | Sell |
22,159
-500
| -2% | -$46.4K | 1.28% | 15 |
|
|
2013
Q4 | $2.08M | Buy |
+22,659
| New | +$2.09M | 1.39% | 17 |
|
Other funds holding JNJ
Northeast Financial Consultants's JNJ Position: Q2 2025 in Review
Northeast Financial Consultants reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q2 2025, selling an estimated $69K and leaving 38,382 shares worth $5.86M. The position accounts for 0.24% of the portfolio, ranked #61.
Northeast Financial Consultants first reported a position in JNJ in Q4 2013 and has held it in 47 quarters since. The position peaked at $7.77M in Q1 2022. 4,082 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.
- Northeast Financial Consultants held 38,382 shares of Johnson & Johnson worth $5.86M as of Q2 2025.
- Northeast Financial Consultants sold 449 Johnson & Johnson shares in Q2 2025, an estimated $69K.
- Johnson & Johnson made up 0.24% of Northeast Financial Consultants's portfolio in Q2 2025, its #61 holding.
- Northeast Financial Consultants first reported a position in Johnson & Johnson in Q4 2013 and has held it in 47 quarters since.
- Northeast Financial Consultants's Johnson & Johnson position peaked at $7.77M in Q1 2022.
- 4,082 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.
Based on Northeast Financial Consultants's 13F filing for Q2 2025, filed 15 Aug 2025.